Company intelligence / Profile preview

Gold Biotechnology

St. Louis, Missouri, United Statesgoldbio.com ↗

Ownership: Private
Employees: ~13
Development stage: Commercial

Overview

Gold Biotechnology provides over 3,000 high-quality molecular biology grade reagents—including luciferin, growth factors, antibiotics, enzymes—for cell and molecular biology research. Their products are used globally by universities, government institutions, and biotech companies. The company does not develop therapeutics or have clinical programs; it focuses on supplying laboratory reagents.

Industry: Chemicals & Materials

Beyond the preview

Go deeper on Gold Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gold Biotechnology.

Explore the full profile